BioSpace News Archive

Press Releases

Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer

September 30, 2025
·
3 min read
Press Releases

Vascarta Announces Completion of Phase 1 Clinical Trial of VAS-101 for the Treatment of Osteoarthritis

September 30, 2025
·
2 min read
Press Releases

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

September 30, 2025
·
3 min read
Press Releases

Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma

September 30, 2025
·
9 min read
Press Releases

Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial

September 30, 2025
·
9 min read
Press Releases

INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal

September 30, 2025
·
5 min read
Press Releases

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

September 30, 2025
·
7 min read
Press Releases

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus

September 30, 2025
·
7 min read
Press Releases

Neura Health Secures $11.4 Million Series A to Fuel National Expansion of Comprehensive, Tech-Enabled Neurology Care Model

September 30, 2025
·
6 min read
Press Releases

MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum

September 30, 2025
·
1 min read